Miglustat-d9 (N-Butyldeoxynojirimycin-d9) hydrochloride is the deuterium labeled Miglustat (hydrochloride). Miglustat hydrochloride is an inhibitor ofglucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1)^[1][2].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

264.79

C₁₀H₁₃D₉ClNO₄

1883545-57-0

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.